ArticlePloS one2015
Public Opinions about Overdiagnosis: A National Community Survey.
Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
34 citing papers in PubMed, 2 syntheses or guidelines pooled it, 73 citations in OpenAlex.
- Patient preferences for breast cancer screening: a systematic review update to inform recommendations by the Canadian Task Force on Preventive Health Care.Systematic reviews · 2024Pooled it
- Assessment of the effects of decision aids about breast cancer screening: a systematic review and meta-analysis.BMJ open · 2017Pooled it
- The effect of information on prostate cancer screening decision process: a discrete choice experiment.BMC health services research · 2020Trial
- Should women aged 70-74 be invited to participate in screening mammography? A report on two Australian community juries.BMJ open · 2018Trial
- Why Most Australians Consider It Valuable to Find Harmless Abnormalities with Diagnostic Tests: A Mixed-Methods Study.Medical decision making : an international journal of the Society for Medical Decision Making · 2026Article
- 'Harm? I don't think so!': medical overuse from the perspective of allied health professionals in Germany - a qualitative study.BMJ open · 2025Article
- Article
- Article
- 'The health care system is more like a business'-medical overuse from the patients' perspective in Germany: a qualitative study.BMJ open · 2024Article
- What do people know and think about medical overuse? an online questionnaire study in Germany.PloS one · 2024Article
- Article
- Implementation of a top five list to identify medical overuse in general practice according to patients' viewpoint in 2019 in France.BMC family practice · 2021Article
- Journalists' views on media coverage of medical tests and overdiagnosis: a qualitative study.BMJ open · 2021Article
- Using a Deliberative Poll on breast cancer screening to assess and improve the decision quality of laypeople.PloS one · 2021Article
- Article
- Article
- Women's Acceptance of Overdetection in Breast Cancer Screening: Can We Assess Harm-Benefit Tradeoffs?Medical decision making : an international journal of the Society for Medical Decision Making · 2020Article
- Risk, Overdiagnosis and Ethical Justifications.Health care analysis : HCA : journal of health philosophy and policy · 2019Article
- Media Coverage of the Benefits and Harms of Testing the Healthy: a protocol for a descriptive study.BMJ open · 2019Article
- Public perceptions of changing the terminology for low-risk thyroid cancer: a qualitative focus group study.BMJ open · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDespite evidence about the "modern epidemic" of overdiagnosis, and expanding disease definitions that medicalize more people, data are lacking on public views about these issues. Our objective was to measure public perceptions about overdiagnosis and views about financial ties of panels setting disease definitions.
methodsWe conducted a 15 minute Computer Assisted Telephone Interview with a randomly selected community sample of 500 Australians in January 2014. We iteratively developed and piloted a questionnaire, with a convenience sample (n=20), then with participants recruited by a research company (n=20). Questions included whether respondents had been informed about overdiagnosis; opinions on informing people; and views about financial ties among panels writing disease definitions.
findingsOur sample was generally representative, but included a higher proportion of females and seniors, typical of similar surveys. American Association for Public Opinion Research response rate was 20% and cooperation rate was 44%. Only 10% (95% CI 8%-13%) of people reported ever being told about overdiagnosis by a doctor. 18% (95% CI 11%-28%) of men who reported having prostate cancer screening, and 10% (95% CI 6%-15%) of women who reported having mammography said they were told about overdiagnosis. 93% (95% CI 90%-95%) agreed along with screening benefits, people should be informed about overdiagnosis. On panels setting disease definitions, 78% (95% CI 74%-82%) felt ties to pharmaceutical companies inappropriate, and 91% (95% CI 82%-100%) believed panels should have a minority or no members with ties. Limitations included questionnaire novelty and complexity.
conclusionsA small minority of Australians surveyed, including those reporting being screened for prostate or breast cancer, reported being informed of overdiagnosis; most believed people should be informed; and a majority felt it inappropriate that doctors with ties to pharmaceutical companies write disease definitions. Results suggest strategies to better inform people about overdiagnosis, and review disease definition processes, have significant public sympathy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.